BAAM
RETA

Baker Avenue Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Baker Avenue Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25
Closed -$950 – 1757
2022
Q4 		$950 Buy
+25
New +$950 ﹤0.01% 1108